Hemodynamic effects of cannabinoids: Coronary and cerebral vasodilation mediated by cannabinoid CB1 receptors

European Journal of Pharmacology

Volumn 423, Issue 2-3, 2001, Pages 203-210

  Wagner, Jens A ^a   Járai, Zoltán ^a   Bátkai, Sándor ^a   Kunos, George ^a,b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

Anandamide; Cannabinoid CB1 receptor; HU 210; Microsphere; R methanandamide

Indexed keywords

ANANDAMIDE; ARGIPRESSIN; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; DEXANABINOL; DRUG ANALOG; GANGLION BLOCKING AGENT; HEXAMETHONIUM; METHANANDAMIDE; RADIOACTIVE MICROSPHERE; RIMONABANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE REGULATION; BRAIN BLOOD VESSEL; CARDIOVASCULAR AUTOREGULATION; CONTROLLED STUDY; CORONARY ARTERY DILATATION; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; DRUG POTENCY; DRUG STABILITY; GANGLION BLOCK; HEART INDEX; HEART STROKE VOLUME; HEMODYNAMIC MONITORING; MALE; MEAN ARTERIAL PRESSURE; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SYMPATHETIC TONE; SYSTEMIC VASCULAR RESISTANCE; TISSUE DISTRIBUTION; VASODILATATION;

ANIMALS; ARACHIDONIC ACIDS; BLOOD PRESSURE; BRAIN; CANNABINOIDS; CORONARY CIRCULATION; CORONARY VESSELS; HEART RATE; HEMODYNAMIC PROCESSES; MALE; PIPERIDINES; POLYUNSATURATED ALKAMIDES; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; TETRAHYDROCANNABINOL; VASCULAR RESISTANCE; VASODILATION;

EID: 0035816432     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(01)01112-8     Document Type: Article

References (43)

1. (R)-methanandamide: A chiral novel anandamide possessing higher potency and metabolic stability
2. Cannabinoid CB1 receptor and endothelium-dependent hyperpolarization in guinea-pig carotid, rat mesenteric and porcine coronary arteries
3. Human brain capillary endothelium: 2-arachidonyl-glycerol interacts with endothelin-1
4. Inhibition by cannabinoid receptor agonists of acetylcholine release from the guinea-pig myenteric plexus
5. Production and physiological actions of anandamide in the vasculature of the rat kidney
6. Isolation and structure of a brain constituent that binds to the cannabinoid receptor
7. 9-THC-dilation of cerebral arterioles is blocked by indomethacin
8. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations
9. Systemic and portal hemodynamic effects of anandamide
10. 2+ channel current
11. Cardiovascular effects of centrally administered endothelin-1 and its relationship to changes in cerebral blood flow
12. Biochemistry and pharmacology of the endocannabinoids arachidonyl-etanolamide and 2-arachidonoylglycerol
13. Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716A
14. Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves
15. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors
16. Cardiovascular effects of endocannabinoids - The plot thickens
17. 1-like cannabinoid receptors
18. Cardiovascular effects of anandamide in anesthetized and conscious normotensive and hypertensive rats
19. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice
20. The radiolabeled microsphere technique in gut blood flow measurement - Current practice
21. Functional CB1 cannabinoid receptors in human vascular endothelial cells
22. Suitability of urethane for physio-pharmacological investigations in various systems
23. Cannabinoid CB1 receptor-mediated inhibition of the neurogenic vasopressor response in the pithed rat
24. Regional cerebral blood flow after marijuana smoking
25. Structure of a cannabinoid receptor and functional expression of the cloned cDNA
26. Carbachol, an acetylcholine receptor agonist, enhances production in rat aorta of 2-arachidonoyl glycerol, a hypotensive endocannabinoid
27. Molecular characterization of a peripheral receptor for cannabinoids
28. Effect of the cannabinoid receptor agonist WIN55212-2 on sympathetic cardiovascular regulation
29. Evidence that anandamide and EDHF act via different mechanisms in rat isolated mesenteric arteries
30. 1 cannabinoid receptor
31. Vanilloid receptors on capsaicin-sensitive sensory nerves mediate relaxation to methanandamide in the rat isolated mesenteric arterial bed and small mesenteric arteries
32. An endogenous cannabinoid as an endothelium-derived vasorelaxant
33. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
34. 2): Identification of cannabinoid receptor subtype selective ligands
35. Hemodynamic disturbances in the rat as a function of the number of microspheres injected
36. 1 receptor mRNA in human vascular cells: Is 2-arachidonoylglycerol a possible vasomodulator?
37. 1 cannabinoid receptor in the hypotensive action of anandamide
38. Mechanism of the hypotensive action of anandamide in the anesthetized rat
39. Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension
40. Cardiovascular effects of (-)-11-OH-delta-8tetrahydrocannabinol dimethylheptyl in rats
41. 1 cannabinoid receptors in haemorrhagic shock
42. Mesenteric vasodilation mediated by endothelial anandamide receptors
43. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide